Global Neuromuscular Blocking Agent (NMBA) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neuromuscular Blocking Agent (NMBA) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neuromuscular Blocking Agent (NMBA) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neuromuscular Blocking Agent (NMBA) by Country/Region, 2017, 2022 & 2028

2.2 Neuromuscular Blocking Agent (NMBA) Segment by Type

2.2.1 Depolarizing

2.2.2 Non-depolarizing

2.3 Neuromuscular Blocking Agent (NMBA) Sales by Type

2.3.1 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2017-2022)

2.3.2 Global Neuromuscular Blocking Agent (NMBA) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neuromuscular Blocking Agent (NMBA) Sale Price by Type (2017-2022)

2.4 Neuromuscular Blocking Agent (NMBA) Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Pharmacy

2.4.4 Others

2.5 Neuromuscular Blocking Agent (NMBA) Sales by Application

2.5.1 Global Neuromuscular Blocking Agent (NMBA) Sale Market Share by Application (2017-2022)

2.5.2 Global Neuromuscular Blocking Agent (NMBA) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neuromuscular Blocking Agent (NMBA) Sale Price by Application (2017-2022)

3 Global Neuromuscular Blocking Agent (NMBA) by Company

3.1 Global Neuromuscular Blocking Agent (NMBA) Breakdown Data by Company

3.1.1 Global Neuromuscular Blocking Agent (NMBA) Annual Sales by Company (2020-2022)

3.1.2 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2020-2022)

3.2 Global Neuromuscular Blocking Agent (NMBA) Annual Revenue by Company (2020-2022)

3.2.1 Global Neuromuscular Blocking Agent (NMBA) Revenue by Company (2020-2022)

3.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Company (2020-2022)

3.3 Global Neuromuscular Blocking Agent (NMBA) Sale Price by Company

3.4 Key Manufacturers Neuromuscular Blocking Agent (NMBA) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neuromuscular Blocking Agent (NMBA) Product Location Distribution

3.4.2 Players Neuromuscular Blocking Agent (NMBA) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neuromuscular Blocking Agent (NMBA) by Geographic Region

4.1 World Historic Neuromuscular Blocking Agent (NMBA) Market Size by Geographic Region (2017-2022)

4.1.1 Global Neuromuscular Blocking Agent (NMBA) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neuromuscular Blocking Agent (NMBA) Annual Revenue by Geographic Region

4.2 World Historic Neuromuscular Blocking Agent (NMBA) Market Size by Country/Region (2017-2022)

4.2.1 Global Neuromuscular Blocking Agent (NMBA) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neuromuscular Blocking Agent (NMBA) Annual Revenue by Country/Region

4.3 Americas Neuromuscular Blocking Agent (NMBA) Sales Growth

4.4 APAC Neuromuscular Blocking Agent (NMBA) Sales Growth

4.5 Europe Neuromuscular Blocking Agent (NMBA) Sales Growth

4.6 Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales Growth

5 Americas

5.1 Americas Neuromuscular Blocking Agent (NMBA) Sales by Country

5.1.1 Americas Neuromuscular Blocking Agent (NMBA) Sales by Country (2017-2022)

5.1.2 Americas Neuromuscular Blocking Agent (NMBA) Revenue by Country (2017-2022)

5.2 Americas Neuromuscular Blocking Agent (NMBA) Sales by Type

5.3 Americas Neuromuscular Blocking Agent (NMBA) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neuromuscular Blocking Agent (NMBA) Sales by Region

6.1.1 APAC Neuromuscular Blocking Agent (NMBA) Sales by Region (2017-2022)

6.1.2 APAC Neuromuscular Blocking Agent (NMBA) Revenue by Region (2017-2022)

6.2 APAC Neuromuscular Blocking Agent (NMBA) Sales by Type

6.3 APAC Neuromuscular Blocking Agent (NMBA) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neuromuscular Blocking Agent (NMBA) by Country

7.1.1 Europe Neuromuscular Blocking Agent (NMBA) Sales by Country (2017-2022)

7.1.2 Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country (2017-2022)

7.2 Europe Neuromuscular Blocking Agent (NMBA) Sales by Type

7.3 Europe Neuromuscular Blocking Agent (NMBA) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neuromuscular Blocking Agent (NMBA) by Country

8.1.1 Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neuromuscular Blocking Agent (NMBA) Revenue by Country (2017-2022)

8.2 Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales by Type

8.3 Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neuromuscular Blocking Agent (NMBA)

10.3 Manufacturing Process Analysis of Neuromuscular Blocking Agent (NMBA)

10.4 Industry Chain Structure of Neuromuscular Blocking Agent (NMBA)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neuromuscular Blocking Agent (NMBA) Distributors

11.3 Neuromuscular Blocking Agent (NMBA) Customer

12 World Forecast Review for Neuromuscular Blocking Agent (NMBA) by Geographic Region

12.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Region

12.1.1 Global Neuromuscular Blocking Agent (NMBA) Forecast by Region (2023-2028)

12.1.2 Global Neuromuscular Blocking Agent (NMBA) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neuromuscular Blocking Agent (NMBA) Forecast by Type

12.7 Global Neuromuscular Blocking Agent (NMBA) Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Neuromuscular Blocking Agent (NMBA) Product Offered

13.1.3 AbbVie Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Offered

13.2.3 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Neuromuscular Blocking Agent (NMBA) Product Offered

13.3.3 Pfizer Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Hengrui Pharmaceutical

13.4.1 Hengrui Pharmaceutical Company Information

13.4.2 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Offered

13.4.3 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hengrui Pharmaceutical Main Business Overview

13.4.5 Hengrui Pharmaceutical Latest Developments

13.5 Abbott Laboratories

13.5.1 Abbott Laboratories Company Information

13.5.2 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Offered

13.5.3 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abbott Laboratories Main Business Overview

13.5.5 Abbott Laboratories Latest Developments

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Company Information

13.6.2 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Offered

13.6.3 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Kabi Main Business Overview

13.6.5 Fresenius Kabi Latest Developments

13.7 Sandoz

13.7.1 Sandoz Company Information

13.7.2 Sandoz Neuromuscular Blocking Agent (NMBA) Product Offered

13.7.3 Sandoz Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sandoz Main Business Overview

13.7.5 Sandoz Latest Developments

13.8 Somerset Therapeutics

13.8.1 Somerset Therapeutics Company Information

13.8.2 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Offered

13.8.3 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Somerset Therapeutics Main Business Overview

13.8.5 Somerset Therapeutics Latest Developments

13.9 Guike Pharmaceutical

13.9.1 Guike Pharmaceutical Company Information

13.9.2 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Offered

13.9.3 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Guike Pharmaceutical Main Business Overview

13.9.5 Guike Pharmaceutical Latest Developments

13.10 Shanghai Pharmaceuticals

13.10.1 Shanghai Pharmaceuticals Company Information

13.10.2 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Offered

13.10.3 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Shanghai Pharmaceuticals Main Business Overview

13.10.5 Shanghai Pharmaceuticals Latest Developments

13.11 Themis Medicare

13.11.1 Themis Medicare Company Information

13.11.2 Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Offered

13.11.3 Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Themis Medicare Main Business Overview

13.11.5 Themis Medicare Latest Developments

13.12 Nanjing King-Friend

13.12.1 Nanjing King-Friend Company Information

13.12.2 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Offered

13.12.3 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Nanjing King-Friend Main Business Overview

13.12.5 Nanjing King-Friend Latest Developments

14 Research Findings and Conclusion

Table 1. Neuromuscular Blocking Agent (NMBA) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neuromuscular Blocking Agent (NMBA) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Depolarizing

Table 4. Major Players of Non-depolarizing

Table 5. Global Neuromuscular Blocking Agent (NMBA) Sales by Type (2017-2022) & (MT)

Table 6. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2017-2022)

Table 7. Global Neuromuscular Blocking Agent (NMBA) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2017-2022)

Table 9. Global Neuromuscular Blocking Agent (NMBA) Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Neuromuscular Blocking Agent (NMBA) Sales by Application (2017-2022) & (MT)

Table 11. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2017-2022)

Table 12. Global Neuromuscular Blocking Agent (NMBA) Revenue by Application (2017-2022)

Table 13. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2017-2022)

Table 14. Global Neuromuscular Blocking Agent (NMBA) Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Neuromuscular Blocking Agent (NMBA) Sales by Company (2020-2022) & (MT)

Table 16. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2020-2022)

Table 17. Global Neuromuscular Blocking Agent (NMBA) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Company (2020-2022)

Table 19. Global Neuromuscular Blocking Agent (NMBA) Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Neuromuscular Blocking Agent (NMBA) Producing Area Distribution and Sales Area

Table 21. Players Neuromuscular Blocking Agent (NMBA) Products Offered

Table 22. Neuromuscular Blocking Agent (NMBA) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Neuromuscular Blocking Agent (NMBA) Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Neuromuscular Blocking Agent (NMBA) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Neuromuscular Blocking Agent (NMBA) Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Neuromuscular Blocking Agent (NMBA) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Neuromuscular Blocking Agent (NMBA) Sales by Country (2017-2022) & (MT)

Table 34. Americas Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country (2017-2022)

Table 35. Americas Neuromuscular Blocking Agent (NMBA) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country (2017-2022)

Table 37. Americas Neuromuscular Blocking Agent (NMBA) Sales by Type (2017-2022) & (MT)

Table 38. Americas Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2017-2022)

Table 39. Americas Neuromuscular Blocking Agent (NMBA) Sales by Application (2017-2022) & (MT)

Table 40. Americas Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2017-2022)

Table 41. APAC Neuromuscular Blocking Agent (NMBA) Sales by Region (2017-2022) & (MT)

Table 42. APAC Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2017-2022)

Table 43. APAC Neuromuscular Blocking Agent (NMBA) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region (2017-2022)

Table 45. APAC Neuromuscular Blocking Agent (NMBA) Sales by Type (2017-2022) & (MT)

Table 46. APAC Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2017-2022)

Table 47. APAC Neuromuscular Blocking Agent (NMBA) Sales by Application (2017-2022) & (MT)

Table 48. APAC Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2017-2022)

Table 49. Europe Neuromuscular Blocking Agent (NMBA) Sales by Country (2017-2022) & (MT)

Table 50. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country (2017-2022)

Table 51. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country (2017-2022)

Table 53. Europe Neuromuscular Blocking Agent (NMBA) Sales by Type (2017-2022) & (MT)

Table 54. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2017-2022)

Table 55. Europe Neuromuscular Blocking Agent (NMBA) Sales by Application (2017-2022) & (MT)

Table 56. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Neuromuscular Blocking Agent (NMBA)

Table 66. Key Market Challenges & Risks of Neuromuscular Blocking Agent (NMBA)

Table 67. Key Industry Trends of Neuromuscular Blocking Agent (NMBA)

Table 68. Neuromuscular Blocking Agent (NMBA) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Neuromuscular Blocking Agent (NMBA) Distributors List

Table 71. Neuromuscular Blocking Agent (NMBA) Customer List

Table 72. Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Neuromuscular Blocking Agent (NMBA) Sales Market Forecast by Region

Table 74. Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Neuromuscular Blocking Agent (NMBA) Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Neuromuscular Blocking Agent (NMBA) Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Neuromuscular Blocking Agent (NMBA) Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share Forecast by Application (2023-2028)

Table 92. AbbVie Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 93. AbbVie Neuromuscular Blocking Agent (NMBA) Product Offered

Table 94. AbbVie Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. AbbVie Main Business

Table 96. AbbVie Latest Developments

Table 97. GlaxoSmithKline Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 98. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Offered

Table 99. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. GlaxoSmithKline Main Business

Table 101. GlaxoSmithKline Latest Developments

Table 102. Pfizer Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 103. Pfizer Neuromuscular Blocking Agent (NMBA) Product Offered

Table 104. Pfizer Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Pfizer Main Business

Table 106. Pfizer Latest Developments

Table 107. Hengrui Pharmaceutical Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 108. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Offered

Table 109. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Hengrui Pharmaceutical Main Business

Table 111. Hengrui Pharmaceutical Latest Developments

Table 112. Abbott Laboratories Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 113. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Offered

Table 114. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Abbott Laboratories Main Business

Table 116. Abbott Laboratories Latest Developments

Table 117. Fresenius Kabi Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 118. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Offered

Table 119. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Fresenius Kabi Main Business

Table 121. Fresenius Kabi Latest Developments

Table 122. Sandoz Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 123. Sandoz Neuromuscular Blocking Agent (NMBA) Product Offered

Table 124. Sandoz Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Sandoz Main Business

Table 126. Sandoz Latest Developments

Table 127. Somerset Therapeutics Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 128. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Offered

Table 129. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Somerset Therapeutics Main Business

Table 131. Somerset Therapeutics Latest Developments

Table 132. Guike Pharmaceutical Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 133. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Offered

Table 134. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Guike Pharmaceutical Main Business

Table 136. Guike Pharmaceutical Latest Developments

Table 137. Shanghai Pharmaceuticals Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 138. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Offered

Table 139. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Shanghai Pharmaceuticals Main Business

Table 141. Shanghai Pharmaceuticals Latest Developments

Table 142. Themis Medicare Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 143. Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Offered

Table 144. Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. Themis Medicare Main Business

Table 146. Themis Medicare Latest Developments

Table 147. Nanjing King-Friend Basic Information, Neuromuscular Blocking Agent (NMBA) Manufacturing Base, Sales Area and Its Competitors

Table 148. Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Offered

Table 149. Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 150. Nanjing King-Friend Main Business

Table 151. Nanjing King-Friend Latest Developments

List of Figures

Figure 1. Picture of Neuromuscular Blocking Agent (NMBA)

Figure 2. Neuromuscular Blocking Agent (NMBA) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neuromuscular Blocking Agent (NMBA) Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neuromuscular Blocking Agent (NMBA) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Depolarizing

Figure 10. Product Picture of Non-depolarizing

Figure 11. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2021

Figure 12. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2017-2022)

Figure 13. Neuromuscular Blocking Agent (NMBA) Consumed in Hospital

Figure 14. Global Neuromuscular Blocking Agent (NMBA) Market: Hospital (2017-2022) & (MT)

Figure 15. Neuromuscular Blocking Agent (NMBA) Consumed in Clinic

Figure 16. Global Neuromuscular Blocking Agent (NMBA) Market: Clinic (2017-2022) & (MT)

Figure 17. Neuromuscular Blocking Agent (NMBA) Consumed in Pharmacy

Figure 18. Global Neuromuscular Blocking Agent (NMBA) Market: Pharmacy (2017-2022) & (MT)

Figure 19. Neuromuscular Blocking Agent (NMBA) Consumed in Others

Figure 20. Global Neuromuscular Blocking Agent (NMBA) Market: Others (2017-2022) & (MT)

Figure 21. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2017-2022)

Figure 22. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application in 2021

Figure 23. Neuromuscular Blocking Agent (NMBA) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Company in 2021

Figure 25. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2017-2022)

Figure 28. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Neuromuscular Blocking Agent (NMBA) Sales 2017-2022 (MT)

Figure 30. Americas Neuromuscular Blocking Agent (NMBA) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Neuromuscular Blocking Agent (NMBA) Sales 2017-2022 (MT)

Figure 32. APAC Neuromuscular Blocking Agent (NMBA) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Neuromuscular Blocking Agent (NMBA) Sales 2017-2022 (MT)

Figure 34. Europe Neuromuscular Blocking Agent (NMBA) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales 2017-2022 (MT)

Figure 36. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country in 2021

Figure 38. Americas Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country in 2021

Figure 39. United States Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region in 2021

Figure 44. APAC Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Regions in 2021

Figure 45. China Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country in 2021

Figure 52. Europe Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country in 2021

Figure 53. Germany Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Country in 2021

Figure 60. Egypt Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Neuromuscular Blocking Agent (NMBA) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Neuromuscular Blocking Agent (NMBA) in 2021

Figure 66. Manufacturing Process Analysis of Neuromuscular Blocking Agent (NMBA)

Figure 67. Industry Chain Structure of Neuromuscular Blocking Agent (NMBA)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles